Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
NGS
Index hopping in Illumina NGS: what it is, why it matters, and how unique dual indexing solves the problem.
May 29, 2025 -
4 min read
Assay Development Workflows
AlphaLISA technology: implementing a rapid, high-throughput screening method for immunomodulatory compounds.
May 23, 2025 -
4 min read
Functional Genomic Screening
CRISPR screening strategies: resistance vs. sensitivity - what’s right for your study?
May 21, 2025 -
3 min read
Cell and Gene Therapy
Precision base editing unlocks new potential for in vivo gene therapies.
May 21, 2025 -
3 min read
Functional Genomic Screening
Unlocking drug secrets: how functional genomic screening reveals valuable mechanism of action insights.
May 21, 2025 -
5 min read
Functional Genomic Screening
Arrayed or pooled library? Make the right first move in your CRISPR screen.
May 21, 2025 -
2 min read
Agricultural Genomics
Selecting the right reference panel for agrigenomics: optimizing low-pass WGS and skim-seq workflows with imputation.
May 14, 2025 -
5 min read
Physiological Model Solutions, Neuroscience Research
Rethinking Alzheimer’s disease with brain-on-chip technology.
May 13, 2025 -
2 min read
